AMG 827 in Subjects With Psoriatic Arthritis

NCT01516957 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

168

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Psoriatic Arthritis

Interventions

DRUG: AMG 827 140
DRUG: Placebo
DRUG: AMG 827 280
DRUG: AMG 827 210

Sponsor

Bausch Health Americas, Inc.